Topic
Topic
Dr. Caroline Elsner discusses personalized mRNA-based therapies for high-risk melanoma in an Oncodaily feature, as the adjuvant vaccine category awaits key readouts from mRNA-4157 and BNT122.
A Physician's Weekly review reframes psoriasis care around the whole patient, calling for comorbidity screening, patient-profile…
A Nature review argues psoriasis immunogenetics — from HLA variants to IL-23/TH17 pathway genetics — is ready to move from discov…
Updated atopic dermatitis guidelines call for proactive, personalized management, framing AD as a chronic disease requiring maint…
Individually manufactured mRNA cancer vaccines are entering the melanoma fight, bringing the pandemic-era platform into dermatolo…
